Hot flashes in perimenopause: why they happen and what helps
This is not medical advice — it is general information based on what you searched for that may help.
General information based on published sources and the symptoms you searched for. This isn't medical or legal advice, a diagnosis or a treatment plan. Please consult a doctor about your own symptoms. If your symptoms are severe or sudden, seek urgent care.
Evidence:Graded per option below
A hot flash (vasomotor symptom) is a sudden feeling of intense heat that spreads rapidly through your chest, neck, and face, often accompanied by flushed skin, sweating, and a racing pulse. In our comprehensive symptoms list, vasomotor episodes are among the most frequently reported.
Episodes typically last between one and five minutes, and they are caused by estrogen fluctuations narrowing the temperature-tolerance zone in your brain. While lifestyle changes and supplements like magnesium for relaxation are widely discussed, clinical evidence shows prescription interventions offer the greatest reduction in daily surges.
Is this normal, and could it be perimenopause?
Yes. Hot flashes affect up to 80% of women during the menopause transition.
In a healthy body, your brain allows a normal range of temperature variation without reacting. When estrogen levels fluctuate and decline during perimenopause, the thermoregulatory center in the hypothalamus becomes hypersensitive. A slight change in ambient heat or internal temperature triggers an exaggerated cooling response: blood vessels rapidly dilate, blood rushes to the skin surface, and sweat glands activate to dissipate heat.
What else could cause hot flashes?
While hormonal transition is the most frequent explanation for women in their 40s and 50s, other conditions can trigger similar flushing:
- Thyroid disorders: Hyperthyroidism causes persistent heat sensitivity, sweating, and heart palpitations.
- Medication reactions: Antidepressants, raloxifene, tamoxifen, and calcium channel blockers can provoke vasodilation.
- Carcinoid or pheochromocytoma tumors: Rare neuroendocrine tumors release vasoactive substances that produce flushing accompanied by severe blood pressure swings.
- Dietary triggers: Caffeine, spicy foods containing capsaicin, and alcohol trigger rapid peripheral vasodilation.
What actually helps: evidence-graded treatments
Clinical research grades hot flash therapies by how effectively they reduce daily episode counts and distress:
| Treatment Option | Evidence Grade | Clinical Trial Summary |
|---|---|---|
| Systemic Hormone Therapy (MHT) | Strong | Gold-standard efficacy; decreases hot flash frequency by up to 90% in randomized trials. |
| NK3 Receptor Antagonists | Strong | Daily non-hormonal prescription tablet targeting hypothalamic thermoregulation directly. |
| Cognitive Behavioral Therapy (CBT) | Moderate | Significantly reduces hot flash distress and perceived burden in clinical trials. |
| SSRI / SNRI Antidepressants | Moderate | Low-dose prescription agents (e.g. venlafaxine, paroxetine) provide modest relief for women who cannot take hormones. |
| Moisture-wicking layered clothing | Comfort only | Natural fibers and breathable performance fabrics allow rapid temperature adjustment during unpredictable daytime surges. |
When evaluating clothing for temperature regulation, focus on breathable weaves and quick-drying fabrics:
Frequent hot flashes are also linked with higher cardiovascular risk, not just discomfort — see our heart health after menopause guide for what that means and what doesn't change about how HRT is used.
What you can do today
- Identify and reduce personal triggers: Track whether coffee, hot tea, spicy seasonings, or alcohol precede your flushing episodes.
- Dress in removable layers: Wear breathable base layers so you can adjust your clothing instantly when a wave of heat begins.
- Carry portable cooling: A small handheld fan and a bottle of cold water can provide immediate physical relief when flushing starts.
- Track daily episodes: Use the Perimenopause symptoms checklist and Symptom tracker and doctor report to document frequency and severity before your next clinic visit.
When to see a doctor and what to ask
If hot flashes interfere with work meetings, daytime activities, or nighttime rest, talk with a healthcare professional.
- How do my medical history and family background influence whether hormonal or non-hormonal therapies are best for me?
- What are the latest safety updates regarding systemic hormone therapy and the FDA boxed warnings?
- Can we review my current medications to ensure none are contributing to flushing?
- What timeframe should I expect before evaluating whether a treatment is working?
Where are you right now?
Still tracking
Not sure if your symptoms fit? Start tracking your daily patterns.
Log and spot your patterns with the symptom checklist →Ready to talk to a doctor
Have an upcoming appointment? Bring structured questions and your history.
Prepare your 10-minute doctor appointment questions →Already on treatment
Evaluating your response or wondering what to adjust next?
Explore evidence-graded treatment and lifestyle options →Related pages
References
- The 2022 Hormone Therapy Position Statement Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2022. Funding: Funded by donations to the NAMS Education & Research Fund; the statement reports no commercial support. Individual panel disclosures not yet reviewed..
- VEOZAH (fezolinetant) tablets, prescribing information. Astellas Pharma US, 2026. Funding: Manufacturer-issued label (FDA-approved text).
- Shufelt CL, Brown V, Carpenter JS et al.. The 2023 nonhormone therapy position statement of The North American Menopause Society. Menopause (The North American Menopause Society, now The Menopause Society), 2023.
- Khalifey HT, Mahereen R, Adwan R et al.. The impact of hormone replacement therapy on cardiovascular health in postmenopausal women: a narrative review. Frontiers in Reproductive Health, 2026.
- Menopause: identification and management (NG23), Recommendations. National Institute for Health and Care Excellence (UK), 2026.
Change log
- : Initial evidence-based article on hot flashes